Attachment G - Sample Client Letter for Past Performance.pdf

PDF 33 KB Posted

Attached to
CBER Biologics Effectiveness and Safety (BEST): Initiative Community Engagement and Development Initiative
Solicitation number
FDA-20-223-SOL-1224066
Issued by

View the file

Other files

File Type Posted
Attachment H - Sample Commitment Letter.pdf PDF
FDA-20-223-SOL-1224066 Section B.pdf PDF
Attachment I - HHS Subcontracting Plan.doc DOC document
SF33 FDA-SOL-1224066.pdf PDF
Attachment F - Past Performance Questionnaire.pdf PDF
Attachment B - Task Order 1 SOW.pdf PDF
Attachment C - Form 3398 Access to Non-Public Info.pdf PDF
Attachment E - Task Order Mapping Matrix.xls XLS spreadsheet
Attachment D - WD_15-4281 (Rev.-16).pdf PDF
Attachment A - IDIQ SOW.pdf PDF

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file
Try for free Login

Text version

The file's text, extracted by GovTribe without its formatting.

SAMPLE CLIENT LETTER

Dear Client, We are currently responding to Solicitation Number FDA-20-223-SOL- 1224066 for the Food and Drug Administration (FDA), Center for Biologics Evaluation and Research (CBER) Biologics Effectiveness and Safety (BEST) Initiative: Community Engagement and Development Initiative.

The FDA placed emphasis on past performance as a key source selection factor and requiring that clients of entities responding to their solicitations be identified and their participation in the evaluation process be requested.

Therefore, enclosed is a Past Performance Evaluation Questionnaire for your completion. We are requesting that you complete the questionnaire and send it directly to the Food and Drug Administration by e-Mail to howard.nesmith@fda.hhs.gov no later than 1:00 PM Central Time on September 4, 2020.

If you have questions regarding the attached questionnaire, or require assistance, please contact Howard Nesmith, FDA Contract Specialist at 870- 543-7459 or howard.nesmith@fda.hhs.gov.

We thank you for your prompt response in this matter.

Sincerely, {Offering Entity} mailto:howard.nesmith@fda.hhs.gov mailto:howard.nesmith@fda.hhs.gov mailto:howard.nesmith@fda.hhs.gov mailto:howard.nesmith@fda.hhs.gov

SAMPLE CLIENT LETTER
SAMPLE CLIENT LETTER

File details come from the government source that posted it. Updated .